Whey Supplementation Research Articles

Effect of different doses of whey proteins on muscle strength, body composition and gene expression of mTOR and MuRF-1 in trained Wistar rats

Introduction: The combination of resistance training (RT) and whey protein supplementation (WPS) is widely practiced by both athletes and recreational exercisers to promote muscle growth and increase strength. Objectiveː This study examined the effect of different doses of whey proteins on muscle strength, body composition and gene expression of mTOR and MuRF-1 in trained Wistar rats. Methodsː 80 male Wistar rats were divided into 8-groups (n=10): sedentary control (C), RT-control (TC), groups consuming whey protein at varying doses (W2, W4, and W6; respectively 2/4/6g/kg/day), and groups consuming whey protein at varying doses combined to RT (TW2, TW4, and TW6; respectively 2/4/6g/kg/day). The RT program was conducted for 12 weeks, three days a week, with the training intensity increasing from 50 to 100% of the rats' body weight. The rats receiving the whey supplement via the gavage method based on their body weight. Resultsː Muscle strength significantly increased in all trained groups (p<0.0001), with a more significant increase in the groups RT and WPS combined. In addition, the expression of mTOR was higher in the RT groups compared to the sedentary groups (p<0.01), but supplementation did not yield significant differences. WPS decreased MuRF-1 expression (p<0.01) independently of RT. Conclusionː In conclusion, RT combined with WPS for 12 weeks improved muscle strength. Furthermore, mTOR expression increased in trained rats, but not in sedentary rats who used different doses of WPS. However, WPS at any dose reduced MuRF-1 expression, independently of RT. Higher WPS doses did not enhance observed gains compared to a lower dose. Keywords: whey protein, body composition, resistance training, mTOR, MuRF-1.

Effects of high-quality protein supplementation on cardiovascular risk factors in individuals with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials

BackgroundUncertainties still existed about the effect of high-quality protein supplementation on cardiovascular disease (CVD) risk factors, although high-quality proteins such as soy and milk proteins have proposed to be beneficial for cardiometabolic health. MethodsA systematic search in PubMed, Web of Science, Cochrane Library, Scopus, and Embase was conducted to quantify the impact of high-quality protein on CVD risk factors. Results63 RCTs on 4 types of high-quality protein including soy protein, milk protein, whey, and casein were evaluated. Soy protein supplementation decreased systolic blood pressure (SBP, -1.42 [-2.68, -0.17] mmHg), total cholesterol (TC, -0.18 [-0.30, -0.07] mmol/L), and low-density lipoprotein cholesterol (LDL-C, -0.16 [-0.27, -0.05] mmol/L). Milk protein supplementation decreased SBP (-2.30 [-3.45, -1.15] mmHg) and total cholesterol (-0.27 [-0.51, -0.03] mmol/L). Whey supplementation decreased SBP (-2.20 [-3.89, -0.51] mmHg), diastolic blood pressure (DBP, -1.07 [-1.98, -0.16] mmHg), triglycerides (-0.10 [-0.17, -0.03] mmol/L), TC (-0.18 [-0.35, -0.01] mmol/L), LDL-C (-0.09 [-0.16, -0.01] mmol/L) and fasting blood insulin (FBI, -2.02 [-3.75, -0.29] pmol/L). Casein supplementation decreased SBP (-4.10 [-8.05, -0.14] mmHg). In the pooled analysis of four high-quality proteins, differential effects were seen in individuals with different health status. In hypertensive individuals, high-quality proteins decreased both SBP (-2.69 [-3.50, -1.87] mmHg) and DBP (-1.34 [-2.09, -0.60] mmHg). In overweight/obese individuals, high-quality proteins improved SBP (-1.40 [-2.22, -0.59] mmHg), DBP (-2.59 [-3.20, -1.98] mmHg), triglycerides (-0.09 [-0.15, -0.02] mmol/L), TC (-0.14 [-0.22, -0.05] mmol/L), LDL-C (-0.12 [-0.16, -0.07] mmol/L), and HDL-C levels (0.02 [0.01, 0.04] mmol/L). According to the benefits on CVD risks factors, whey ranked top for improving cardiometabolic health in hypertensive or overweight/obese individuals. ConclusionOur study supports a beneficial role of high-quality protein supplementation to reduce CVD risk factors. Further studies are still warranted to investigate the effects of different high-quality proteins on CVD risks in individuals with cardiometabolic disorders.

Explorative Characterization of GI Complaints, General Physical and Mental Wellbeing, and Gut Microbiota in Trained Recreative and Competitive Athletes with or without Self-Reported Gastrointestinal Symptoms.

The current state of the literature lacks a clear characterization of gastrointestinal (GI) symptoms, gut microbiota composition, and general physical and mental wellbeing in well-trained athletes. Therefore, this study aimed to characterize differences in self-reported symptoms, gut microbiota composition, and wellbeing (i.e., sleep quality, mood, and physical (PHQ) and mental wellbeing) between athletes with and without GI symptoms. In addition, we assessed the potential impact of a 3-week multi-ingredient fermented whey supplement in the GI complaints group, without a control group, on the gut microbiota and self-reported GI symptoms and wellbeing. A total of 50 athletes (24.7 ± 4.5 years) with GI issues (GI group at baseline, GI-B) and 21 athletes (25.4 ± 5.3 years) without GI issues (non-GI group, NGI) were included. At baseline, there was a significant difference in the total gastrointestinal symptom rating scale (GSRS) score (24.1 ± 8.48 vs. 30.3 ± 8.82, p = 0.008) and a trend difference in PHQ (33.9 ± 10.7 vs. 30.3 ± 8.82, p = 0.081), but no differences (p > 0.05) were seen for other outcomes, including gut microbiota metrics, between groups. After 3-week supplementation, the GI group (GI-S) showed increased Bifidobacterium relative abundance (p < 0.05), reported a lower number of severe GI complaints (from 72% to 54%, p < 0.001), and PHQ declined (p = 0.010). In conclusion, well-trained athletes with GI complaints reported more severe GI symptoms than an athletic reference group, without showing clear differences in wellbeing or microbiota composition. Future controlled research should further investigate the impact of such multi-ingredient supplements on GI complaints and the associated changes in gut health-related markers.

Comparative Efficacy of Different Protein Supplements on Muscle Mass, Strength, and Physical Indices of Sarcopenia among Community-Dwelling, Hospitalized or Institutionalized Older Adults Undergoing Resistance Training: A Network Meta-Analysis of Randomized Controlled Trials.

Aging-related sarcopenia exerts harmful impacts on muscle mass, strength, and physical mobility. Protein supplementation has been demonstrated to augment efficacy of resistance training (RT) in elderly. This study compared the relative effects of different protein supplements on muscle mass, strength, and mobility outcomes in middle-aged and older individuals undergoing RT. A comprehensive search of online databases was performed to identify randomized controlled trials (RCTs) examining the efficacy of protein supplement plus RT in untrained community-dwelling adults, hospitalized, or institutionalized residents who suffered acute or chronic health conditions. Network meta-analysis (NMA) was performed using a frequentist method for all analyses. Treatment effects for main outcomes were expressed as standard mean difference (SMD) with 95% confidence interval (CI). We used the surface-under-the cumulative-ranking (SUCRA) scores to rank probabilities of effect estimation among all identified treatments. Meta-regression analyses were performed to identify any relevant moderator of the treatment efficacy and results were expressed as β with 95% credible interval (CrI). We finally included 78 RCTs (5272 participants) for analyses. Among the six protein sources identified in this NMA, namely whey, milk, casein, meat, soy, and peanut, whey supplement yielded the most effective treatments augmenting efficacy of RT on muscle mass (SMD = 1.29, 95% CI: 0.96, 1.62; SUCRA = 0.86), handgrip strength (SMD = 1.46, 95% CI: 0.92, 2.00; SUCRA = 0.85), and walking speed (SMD = 0.73, 95% CI: 0.39, 1.07; SUCRA = 0.84). Participant's health condition, sex, and supplementation dose were significant factors moderating the treatment efficacy on muscle mass (β = 0.74; 95% CrI: 0.22, 1.25), handgrip strength (β = -1.72; 95% CrI: -2.68, -0.77), and leg strength (β = 0.76; 95% CrI: 0.06, 1.47), respectively. Our findings suggest whey protein yields the optimal supplements to counter sarcopenia in older individuals undergoing RT.

Development of non-destructive methods for the assessment of authenticity of sports whey protein supplements

In the category of sports supplements, whey protein powder is one of the popular supplements for muscle building applications. Therefore, verification of the sport supplements as authentic products has become a universal concern. This work aimed to propose vibrational spectroscopy including near infrared (NIR) and infrared (IR) as rapid and non-destructive testing tools for the detection and quantification of maltodextrin, milk powder and milk whey powder in whey protein supplements. Initially, principal component analysis was applied to data for pattern recognition and the results displayed a fine pattern of discrimination. Partial least square discrimination analysis (PLS-DA) and K-nearest neighbours (KNN) were exploited as supervised method modelling classification. This process was done in order to respond to two vital questions whether the sample is adulterated or not and what is the kind of adulteration. PLS-DA showed better classification results rather than KNN according to the figure of merits of the model. Partial least square regression (PLSR) was employed on pre-treated spectra to quantify the amount of adulteration in sport whey supplements. Eventually, it seems vibrational spectroscopy could be implemented as a simple, and low-cost analysis method for the detection and quantification of mentioned adulterants in whey protein supplements.

Effect of a Co-Feed Liquid Whey-Integrated Diet on Crossbred Pigs' Fecal Microbiota.

This study assessed the potential effect of a co-feed liquid whey-integrated diet on the fecal microbiota of 14 crossbred pigs. The experimental design was as follows: seven pigs were in the control group, fed with a control feed, and seven were in the experimental group, fed with the same control feed supplemented daily with liquid whey. The collection of fecal samples was conducted on each animal before the dietary treatment (T0) and one (T1), and two (T2) months after the beginning of the co-feed integration. In addition, blood samples were collected from each pig at the same time points in order to evaluate the physiological parameters. Taxonomic analysis showed a bacterial community dominated by Firmicutes, Bacteroidetes, Spirochaetes, and Proteobacteria phyla that populated the crossbred pig feces. The diversity metrics suggested that the co-feed supplementation affected some alpha diversity indexes of the fecal microbiota. In addition, the differential abundance analysis at the genus level revealed significant differences for various genera, suggesting that the liquid whey supplementation potentially influenced a part of the bacterial community over time. Spearman's correlations revealed that the differential abundant genera identified are positively or negatively correlated with the physiological parameters.

The Impact of Whey Protein Supplementation on Sarcopenia Progression among the Elderly: A Systematic Review and Meta-Analysis

We conducted a systematic literature review and meta-analysis to investigate the role of whey protein supplementation in the functioning of the elderly with sarcopenia. The aim was to investigate the available scientific evidence and determine the best recommendations with respect to whey protein supplementation in sarcopenic patients. Methods: Databases, including CINAHL, Embase PubMed, and Web of Science, were searched from database inception until 31 December 2022 for randomised controlled trials (RCTs) comparing the efficacy of whey protein supplementation in the elderly with sarcopenia. Data on study design, risk of bias, patient, illness, and treatment characteristics from each study were independently extracted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). The tool “assessing risk of bias” from the Cochrane Handbook was used to evaluate the quality of the included papers. Results: The search identified 629 records; 590 articles were excluded as duplicates or after evaluation at the title or abstract level. Out of 39 full-text articles that were reviewed, 29 were excluded for not fulfilling the inclusion criteria. There is some evidence that whey protein supplementation combined with age-appropriate physical exercise might improve muscle mass and lower limb function in the elderly with sarcopenia. The present meta-analysis demonstrated overall that whey supplementation does not improve any of the tested sarcopenia-linked parameters. However, we found that study duration (weeks) and age significantly affect the handgrip strength rate and the chair and stand test rate, respectively, so consideration should be given to oral supplementation combined with the age of participants and an appropriate physical activity as a form of sarcopenia prevention in the high-risk group.

The Role of Whey Supplementation on Sensation Seeking, Parent-child Relationship, Family Communication, Anger and Sex Desire Among Athletes, Athletes Using Whey and Normal Population

The purpose of this research was to examine the role of Whey protein in inducing changes in sensation-seeking, parent-child relationships, family relationships, anger, and sexual desire among regular male athletes, supplement-consuming athletes, and ordinary men in the city of Isfahan. The study population included regular athletes, supplement consumers, and ordinary men in Isfahan. The research method was causal-comparative. The sample size consisted of 30 individuals per group, with the Whey consuming group selected through convenience sampling, and the other two groups were matched and chosen accordingly. The instruments used included scales for family relationships; attachment to parents; sensation-seeking; anger expression, and sexual desire. The research data were analyzed using descriptive statistics (mean and standard deviation) and inferential statistics (multivariate analysis of covariance) through SPSS software, version 23. The results indicated that the three groups did not significantly differ in the research variables. Thus, it can be stated that Whey protein does not play a significant role in creating changes in the psychological and family-related variables mentioned in the studied groups.

Anti-aging trait of whey protein against brain damage of senile rats

Aging mammalian results in impaired bio-functions and neurological disorders. The current study investigated whether whey protein (WP) syrup supplementation may improve age-related changes in diseased brain indicators like tau protein, β-amyloid and α-amylase. The study was carried out in conjunction with immunohistochemistry, histology, and flow cytometry of apoptosis. At the ages of 8 and 30 months, Wistar albino rats (Rattus novergicus) were divided into four groups (n = 8; G1; 8 months old rats; G2, 8 months old rats supplemented WP; G3, 30 months old rats; G4, 30 months old rats supplemented WP), with or without whey syrup administration. For 2 months, oral whey supplementation in 2 mL/kg doses is given twice a day every 12 h. Rats were sacrificed, and their brains were subjected to biochemical, histological, immunohistochemistry, and flow cytometric investigations. Aged rats had lower levels of superoxide dismutase (SOD), adenosine triphosphate (ATP), serotonin (5-HT), and dopamine (DA). These observations were parallel with increased inflammatory markers [tumor necrosis factor α- and 5-lipoxygenase (5-LO)], lipid peroxidation products (MDA), as well as apoptotic marker caspase-3, annexin-v, tau protein, β-amyloid, and α-amylase. Whey administration to aged rats reduced inflammatory and oxidative stress markers as well as improved neurotransmitters, tau protein, β-amyloid, and α-amylase. The advantages of supplementation were validated by improved histology and immunohistochemistry in aged rats’ cerebrum, cerebellum, and hippocampus. In addition, apoptosis was reduced, according to flow cytometry analysis of annexin-v. In conclusion, WP contains amino acids and bioactive compounds that could decrease brain oxidative stress and restore normal metabolic function. Furthermore, increased antioxidant defense and DA and 5-HT neurotransmitters, while decreasing brain tau protein and β-amyloid, were associated with better histology in aged rats’ cerebrum, cerebellum, and hippocampus.

Impact of Chronic Use of Whey Protein Isolate in Two Doses Using an Experimental Model

There is limited evidence in the scientific literature regarding the chronic use of whey protein and its potentially adverse effects or toxicity. We evaluated the impact of chronic use of whey protein in two doses using an experimental model. Adult male Wistar rats (n = 30) were supplemented with two different doses: 3125 mg/kg and 6250 mg/kg of whey protein isolate for 90 days. Biochemical, hematological, tissue, morphological, and behavioral analysis were evaluated. The whey-treated groups significantly increased their weight compared to the control (p &lt; 0.05). Biochemical and hematological parameters were unchanged, except for glucose, higher in the 6250 mg/kg group (p &lt; 0.05). The behavioral analysis showed no relevant difference (p &gt; 0.05). The organs analysis showed an absolute increase in liver, right kidney, and heart weights in the whey-treated group compared to the control (p &lt; 0.05). This study suggests that whey protein isolate has no toxicity when supplemented at such doses for 90 days. These doses also appeared to have the same effect regarding weight gain and absolute organs weight. This research corroborates with current literature; however, further work is needed to safely investigate the chronic use of whey supplements at a higher dose.

Bovine Whey Supplementation in a High-Fat Diet Fed Rats Alleviated Offspring’s Cardiac Injury

Abstract The research study determined the effect of bovine whey supplementation in rats fed on high-fat diet on occurrence of myocardium damage and disfunction in its offspring. Eighty virgin female rats (Rattus norvegicus) (100-110 g body weight) were used for this study. Following mating, the pregnant rats were categorized into four groups: control, whey supplemented (W), high-fat diet (FD) and high-fat diet and whey supplemented group (FD+W). Whey supplementation alone or in combination with a high-fat diet was administered every other day during the gestation and lactation period. Offspring rats at the age of 1, 7, 14 and 21-day post-partum were sacrificed and their hearts were processed for histological, p53 immunohistochemistry, transmission electron microscopy and biochemical markers for cell damage. Offspring from the FD+W group exhibited improvement of the myocardium histological picture. Moreover, there was a lower accumulation of lipid deposits and regular organization of cardiomyocyte bands and intercalated discs. A lower p53 immune reaction and lower single strand DNA damage was noticed. The levels of the antioxidant enzymes (SOD and catalase) in the myocardium were increased, whereas the contents of IL6, MDA and caspase-3 were decreased, resulting in a reduction in inflammation and cell death. In conclusion, supplementation of whey to mother rats fed with high-fat diet alleviated the markers of cardiomyocyte injury in its offspring due to its antioxidant effect.

Studies on the anti-aging properties of bovine whey supplementation on reproductive hormonal profiles and sperm structure and function of adult and senile rats

The purpose of this study was to investigate how well whey might protect against aging related alterations in sperm structure, seminal and antioxidant enzymes and serum hormonal profiles. Male Wistar albino rats aged 8 and 30-months were divided into two primary groups with or without whey supplementation (n = 8). After the experiments of whey supplementation, the rats were euthanized, blood was collected, and serum was separated. Sperm ultrastructure and flow cytometry of annexin-V and mitochondrial membrane potential were carried out. Seminal antioxidant and malondialdehyde concentrations were determined. Serum hormonal profiles of testosterone, growth (GH), follicle stimulating hormone (FSH), luteinizing hormone (LH) and thyroid stimulating hormone (TSH) as well as pituitary gland ultrastructure were investigated. Results showed that whey supplementation improved the structure and function of sperm and seminal fluid as well as the serum hormonal levels of adult. In aged rats, whey supplementation increased the serum levels of GH, FSH, LH and TSH as well as seminal superoxide dismutase. Whey supplementation also caused reduction of seminal alkaline and acid phosphatases and lipid peroxidation in aged rat compared to that in adult ones. They also improved sperm motility and viability but reduced sperm abnormalities by increasing sperm mitochondrial membrane potential and lowering annexin v levels. In conclusion, whey contains antioxidant components that alleviated oxidative stress involved in damaging sperm macromolecules during aging process.

Whey Protein Supplementation Improves the Glycemic Response and May Reduce Non-Alcoholic Fatty Liver Disease Related Biomarkers in Women with Polycystic Ovary Syndrome (PCOS).

Polycystic ovary syndrome (PCOS) increases type 2 diabetes and non-alcoholic fatty liver disease (NAFLD) with insulin resistance. We hypothesized that a 35 g whey preload would improve insulin sensitivity and glucose handling while reducing biomarkers associated with NAFLD. Twenty-nine age-matched women (CON = 15, PCOS = 14) completed oral glycemic tolerance tests following baseline (Day 0) as well as an acute (Day 1) and short-term whey supplementation (Day 7). Whey had an interaction effect on glucose (p = 0.02) and insulin (p = 0.03), with glucose remaining stable and insulin increasing with whey supplementation. Insulin sensitivity (p < 0.01) improved with whey associated with increased glucagon secretion (p < 0.01). Alanine aminotransferase (ALT), and aspartate aminotransferase (AST) remained unchanged, but “day” had an effect on the AST:ALT ratio (p = 0.04), whereas triglycerides and sex hormone binding globulin overall were greater in the PCOS group (p < 0.05). Total cholesterol decreased in PCOS (by 13%) and CON (by 8%) (NS). HepG2 cells treated with plasma from participants before and after whey decreased lipid accumulation in the PCOS group after whey (p < 0.05). Whey provided an insulinogenic and glycemic homeostatic effect in women with PCOS with the potential to combat NAFLD-consequences.

Comparison of short-term hypocaloric high-protein diets with a hypocaloric Mediterranean diet: Effect on body composition and health-related blood markers in overweight and sedentary young participants

ObjectivesThe aim of the present study was to compare the short-term effects of a hypocaloric Mediterranean diet and two high protein diets, with and without whey protein supplementation, on body composition, lipidemic profile, and inflammation and muscle-damage blood indices in overweight, sedentary, young participants. MethodsThirty-three young, overweight, male and female participants (mean ± SD age: 22.8 ± 4.8 y; body mass: 85.5 ± 10.2 kg; body fat percentage: 34.3% ± 8.1%) were randomly allocated to three different hypocaloric (−700 kcal/d) diets: a Mediterranean diet (MD; n = 10), a high-protein diet (HP; n = 10) diet, and a high-protein diet with whey supplementation (n = 10). The intervention lasted 6 wk. Body composition and biochemical indices were evaluated 1 wk before and after the nutritional interventions. ResultsBody and fat mass were decreased in the MD and HP groups (−3.5% ± 1.1% and −5.9% ± 4.2% for body and fat mass respectively in MD, and −1.7% ± 1.2% and −2.0% ± 1.8% for body and fat mass respectively in HP;P < 0.05), with no significant decline of fat-free mass observed in the MD group. The MD group's diet beneficially altered the lipid profile (P < 0.05), but the HP and HPW groups’ diets did not induce significant changes. Subclinical inflammation and muscle-damage indices significantly increased in the HP and HPW groups (7.4% ± 3.5% and 66.6% ± 40.1% for neutrophils and CRP respectively in HP, and 14.3% ± 6.4% and 266.6% ± 55.1% for neutrophils and CRP respectively in HPW; P < 0.05) but decreased in the MD group (1.8% ± 1.2% and −33.3% ± 10.1% for neutrophils and CRP respectivelyc; P < 0.05). Energy intake of carbohydrates and proteins were significantly related to the changes in body composition and biochemical blood markers (r = −0.389 and −0.889; P < 0.05). ConclusionsAmong the three hypocaloric diets, only the Mediterranean diet induced positive changes in body composition and metabolic profile in overweight, sedentary individuals.

Daily Consumption of a Specially Formulated Essential Amino Acid-Based Dietary Supplement Improves Physical Performance in Older Adults With Low Physical Functioning.

We have investigated the hypothesis that nutritional supplementation of the diet in low-physical-functioning older individuals with a specially formulated composition based on essential amino acids (EAAs) would improve physical function as compared to supplementation with the same amount of whey protein. A third group of comparable volunteers were given nutrition education but no supplementation of the diet. After 6 weeks of whey protein supplementation (n = 32), there was no effect on the distance walked in 6 minutes, but the distance walked improved significantly from the pre-value after 12 weeks of whey supplementation. EAA consumption (n = 28) significantly improved walking distance at both 6 and 12 weeks. The distance walked at 12 weeks (419.0 ± 25.0 m) was 35.4 m greater than the pre-value of 384.0 ± 23.0 m (p < .001). The increase in distance walked by the EAA group was also significantly greater than that in the whey group at both 6 and 12 weeks (p < .01). In contrast, a decrease in distance walked was observed in the control group (n = 32) (not statistically significant, NS). EAA supplementation also improved grip strength and leg strength, and decreased body weight and fat mass. Plasma low-density lipoprotein concentration was significantly reduced in the EAA group, as well as the concentration of macrophage migration inhibitory factor. There were no adverse responses in any groups, and compliance was greater than 95% in all individuals consuming supplements. We conclude that dietary supplementation with an EAA-based composition may be a beneficial therapy in older individuals with low physical functional capacity. Clinical Trials Registration Number: This study was registered with ClinicalTrials.gov: NCT03424265-"Nutritional interventions in heart failure."

Supplementation with liquid whey and ACIDAL® ML in drinking water affect gut pH and microflora and productive performance in laying hens

ABSTRACT 1. As the use of antibiotics as growth promoters has been banned in many regions, there has been an on-going search for possible alternative compounds, such as prebiotics and organic acids. 2. This study was conducted to investigate the influence of liquid whey (LW) and organic acid (ACIDAL® ML) supplementation on performance, eggs characteristics, gut pH and health status in laying hens. 3. Seven hundred and fifty, Isa Brown chicks were randomly assigned to five treatments groups (n = 150) and each treatment had five replicates of 30 birds each. The birds were reared for 48 weeks. The treatments were administered in the drinking water at doses of: 250 ml/l of LW (Lacto25), 500 ml/l of LW (Lacto50) or 1 ml/l of ACIDAL® ML (Aci). A positive control group (T+) was treated with 500 mg/l of Tetracolivit (an antibiotic). The negative control group (T-) did not receive any treatment in the drinking water. 4. Administration of LW or ACIDAL® ML in the drinking water reduced (P < 0.05) the pH in the crop, proventriculus, ileum and caeca, as well as total coliform bacteria and E. coli, but increased Lactobacillus spp. in the ileum and caecum, compared to the negative control. 5. Oviposition was earlier in the birds in both the Lacto50 and Aci groups. The weight of birds at first lay and point of lay in the four treated groups was higher than those in negative control group. Furthermore, egg production was increased by 10.44% in birds receiving Lacto25, but the weight and quality traits were unaffected, while the egg shell ratio was higher in the Aci group compared to the other treatments. 6. The data indicated that addition of LW or ACIDAL® ML improved hens’ performance by modifying gut pH and microflora.

The effect of whey supplementation on the nutritive value of fermented forage from semi-natural grassland

Cilj istraživanja bio je utvrditi utjecaj dodatka sirutke u prahu provenutoj biljnoj masi poluprirodnog travnjaka na hranidbenu vrijednost fermentirane krme i kvalitetu fermentacije u silosu. Korišteno je pet razina dodatka sirutke u prahu kg-1 silirane suhe tvari (ST) krme poluprirodnog travnjaka: (i) 0 g; (ii) 13 g; (iii) 65 g; (iv) 130 g; (v) 260 g (tretmani T0, T13, T65, T130 i T260 respektivno). Biljna je masa silirana u laboratorijskim silosima. Silosi su otvoreni 40. dan od zatvaranja radi procjene hranidbene vrijednosti fermentirane krme i kvalitete NIR spektroskopijom. Zaključeno je da sirutka u prahu, kao dodatak provenutoj biljnoj masi poluprirodnog travnjaka prilikom siliranja, linearno povećava sadržaj ST (P&amp;lt;0,05), korigirane ST (KST) (P&amp;lt;0,01), sirovih proteina (SP) (P&amp;lt;0,001), neutralnih detergent vlakana (NDV) (P&amp;lt;0,001), fermentirajuće metaboličke energije u metaboličkoj energiji (FME/ME) (P&amp;lt;0,001), probavljivost organske tvari u ST (D-vrijednost) (P&amp;lt;0,001), faktor konzumacije za goveda (P&amp;lt;0,001), faktor konzumacije za ovce (P&amp;lt;0,001), a smanjuje pH vrijednost (P&amp;lt;0,05), sadržaj organske tvari (OT) (P&amp;lt;0,001), sadržaj amonijskog dušika (NH3-N) (P&amp;lt;0,001) i rezidua šećera (P&amp;lt;0,001) u fermentiranoj krmi.

Effects of Prolonged Whey Protein Supplementation and Resistance Training on Biomarkers of Vitamin B12 Status: A 1-Year Randomized Intervention in Healthy Older Adults (the CALM Study).

We investigated the effect of long-term whey supplementation on biomarkers of B12 status in healthy older adults subjected to different schemes of supplements and exercise. The total study population examined at baseline consisted of 167 healthy older adults (age ≥ 65 year) who were randomized to 1-y intervention with two daily supplements of (1) whey protein (3.1 µg B12/day) (WHEY-ALL), (2) collagen (1.3 µg B12/day) (COLL), or (3) maltodextrin (0.3 µg B12/day) (CARB). WHEY-ALL was comprised of three groups, who performed heavy resistance training (HRTW), light resistance training (LITW), or no training (WHEY). Dietary intake was assessed through 3-d dietary records. For the longitudinal part of the study, we included only the participants (n = 110), who met the criteria of ≥ 50% compliance to the nutritional intervention and ≥ 66% and ≥ 75% compliance to the heavy and light training, respectively. Fasting blood samples collected at baseline and 12 months and non-fasting samples collected at 6 and 18 months were examined for methylmalonic acid, B12 and holotranscobalamin. At baseline, the study population (n = 167) had an overall adequate dietary B12 intake of median (range) 5.3 (0.7–65) µg/day and median B12 biomarker values within reference intervals. The whey intervention (WHEY-ALL) caused an increase in B12 (P < 0.0001) and holotranscobalamin (P < 0.0001). In addition, methylmalonic acid decreased in the LITW group (P = 0.04). No change in B12 biomarkers was observed during the intervention with collagen or carbohydrate, and the training schedules induced no changes. In conclusion, longer-term daily whey intake increased plasma B12 and holotranscobalamin in older individuals. No effect of intervention with collagen or carbohydrate or different training regimes was observed. Interestingly, the biomarkers of B12 status appeared to be affected by fasting vs. non-fasting conditions during sample collection.

Postpartum supplementation with fermented ammoniated condensed whey altered nutrient partitioning to support hepatic metabolism

Our previously published paper demonstrated that fermented ammoniated condensed whey (FACW) supplementation improved feed efficiency and metabolic profile in postpartum dairy cows. The objective of this study was to further explore the effects of FACW supplementation on liver triglyceride content, hepatic gene expression and protein abundance, and plasma biomarkers related to liver function, inflammation, and damage. Individually fed multiparous Holstein cows were blocked by calving date and randomly assigned to postpartum (1 to 45 d in milk, DIM) isonitrogenous treatments: control diet (n = 20) or diet supplemented with FACW (2.9% dry matter of diet as GlucoBoost; Fermented Nutrition, Luxemburg, WI, replacing soybean meal; n = 19). Liver biopsies were performed at 14 and 28 DIM for analysis of mRNA expression, protein abundance, and liver triglyceride content. There was marginal evidence for a reduction in liver triglyceride content at 14 DIM in FACW-supplemented cows compared with the control group. Cows supplemented with FACW had greater mRNA expression of glucose-6-phosphatase at 14 DIM relative to control. Supplementation with FACW increased mRNA expression of pyruvate carboxylase (PC), but did not alter cytosolic phosphoenolpyruvate carboxykinase (PCK1), resulting in a 2.4-fold greater PC:PCK1 ratio for FACW-supplemented cows compared with control. There was no evidence for a FACW effect on mRNA expression of propionyl-CoA carboxylase nor on mRNA expression or protein abundance of lactate dehydrogenase A or B. Cows supplemented with FACW had lower plasma urea nitrogen compared with control. Plasma l-lactate was greater for FACW-supplemented cows compared with control at 2 h before feeding time at 21 DIM. There was no evidence for altered expression of IL1B or IL10, or blood biomarkers related to liver function and damage. Greater glucose-6-phosphatase and PC gene expression, together with greater blood glucose and similar milk lactose output, suggests that FACW increased the supply of glucose precursors, resulting in greater gluconeogenesis between 3 and 14 DIM. Greater hepatic PC:PCK1 ratio, together with previously reported decreased plasma β-hydroxybutyrate and the marginal evidence for lower liver triglyceride content at 14 DIM, suggests greater hepatic capacity for complete oxidation of fatty acids in FACW-supplemented cows compared with control. Overall, improvements in metabolite profile and feed efficiency observed with postpartum supplementation of FACW may be attributed to increased gluconeogenic and anaplerotic precursors, most likely propionate, due to modulated rumen fermentation.

Whey for Sarcopenia; Can Whey Peptides, Hydrolysates or Proteins Play a Beneficial Role?

As the human body ages, skeletal muscle loses its mass and strength. It is estimated that in 10% of individuals over the age of 60, this muscle frailty has progressed to sarcopenia. Biomarkers of sarcopenia include increases in inflammatory markers and oxidative stress markers and decreases in muscle anabolic markers. Whey is a high-quality, easily digested dairy protein which is widely used in the sports industry. This review explores the evidence that whey protein, hydrolysates or peptides may have beneficial effects on sarcopenic biomarkers in myoblast cell lines, in aged rodents and in human dietary intervention trials with the older consumer. A daily dietary supplementation of 35 g of whey is likely to improve sarcopenic biomarkers in frail or sarcopenia individuals. Whey supplementation, consumed by an older, healthy adult certainly improves muscle mTOR signaling, but exercise appears to have the greatest benefit to older muscle. In vitro cellular assays are central for bioactive and bioavailable peptide identification and to determine their mechanism of action on ageing muscle.